Categories: Business News

AstraZeneca 'magic' faces rare test after trial failure, share slide

(Corrects name of rare neurological disorder, to ATTRv-PN, in paragraph 9) By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca's long-time CEO Pascal Soriot has rarely put a…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: July 24, 2026 20:18:08 IST

(Corrects name of rare neurological disorder, to ATTRv-PN, in paragraph 9) By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: July 24, 2026 20:18:08 IST

Recent Posts

Why so many bruises? Signs your child may have haemophilia

Berlin (dpa) - The baby slips in the tub and Mum or Dad grabs their…

July 24, 2026

'A Knight of the Seven Kingdoms' season 2 was "10 times harder" to film, says showrunner Ira Parker

Washington [US], July 24 (ANI): Production on 'A Knight of the Seven Kingdoms' season 2…

July 24, 2026

India concludes WTO Trade Policy Review; members seek clarifications on PLI, QCOs, trade policy measures

New Delhi [India], July 24 (ANI): India concluded its eighth Trade Policy Review (TPR) at…

July 24, 2026